23andMe sued by state attorneys general over plans to sell genetic data
Source: SeekingAlpha
2025-06-10 15:55:51 ET
More on 23andMe
- 23andMe seeks second auction as ex-CEO outbids Regeneron
- Regeneron to buy 23andMe for $256M in court-supervised sale
- Seeking Alpha’s Quant Rating on 23andMe
- Historical earnings data for 23andMe
- Financial information for 23andMe
Read the full article on Seeking Alpha
For further details see:
23andMe sued by state attorneys general over plans to sell genetic data
Regeneron Pharmaceuticals Inc.
NASDAQ: REGN
REGN Trading
0.51% G/L:
$781.46 Last:
155,403 Volume:
$769.17 Open:
REGN Latest News
March 12, 2026 04:04:00 am
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
REGN Stock Data
$80,621,924,056
100,116,656
N/A
714
N/A
Biotechnology & Life Sciences
Healthcare
US
Tarrytown
